Tagged: "Jakavi"

Jakavi is an anti-cancer medicine that contains the active substance Ruxolitinib. It is used in the treatment of myelofibrosis (cancer of bone marrow), polycythaemia vera (cancer of the blood), and graft-versus-host disease (GVHD), a complication of hematopoietic stem-cell transplant.

Showing the single result